SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-016305
Filing Date
2020-06-30
Accepted
2020-06-30 16:09:08
Documents
3
Period of Report
2020-08-03
Effectiveness Date
2020-06-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea123658-def14a_oramedpharma.htm DEF 14A 483148
2 GRAPHIC proxy_1.jpg GRAPHIC 1535022
3 GRAPHIC proxy_2.jpg GRAPHIC 455252
  Complete submission text file 0001213900-20-016305.txt   3225519
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 201002425
SIC: 2834 Pharmaceutical Preparations